Solid Tumors – PC/BCAntineoplastic Therapies After Start of Study Drug (011)

Patients, n (%)

ZOMETA® ZOMETA

4 mg 8/4 mg Placebo

Antineoplastic therapy N = 254 N = 265 N = 247

37

Any 192 (75.6) 184 (69.4) 181 (73.3)

Carboplatin 74 (29.1) 58 (21.9) 65 (26.3)

Paclitaxel 52 (20.5) 58 (21.9) 46 (18.6)

Gemcitabine hydrochloride 39 (15.4) 28 (10.6) 25 (10.1)

Cisplatin 37 (14.6) 46 (17.4) 41 (16.6)

PTT 8.2-4

Previous slide

Next slide

Back to first slide

View graphic version